Influence of Patient Choice of Intrathecal Morphine on Post-cesarean Delivery Pain.
| Status: | Completed |
|---|---|
| Conditions: | Chronic Pain |
| Therapuetic Areas: | Musculoskeletal |
| Healthy: | No |
| Age Range: | 18 - 50 |
| Updated: | 4/21/2016 |
| Start Date: | August 2011 |
| End Date: | July 2013 |
This is a randomized controlled study that will place patients into a "choice" and a "no
choice" group. The choice group will be able to choose between receiving 100 mcg or 200 mcg
intrathecal morphine. The no choice group will be randomized to receive either 100 mcg or
200 mcg of intrathecal morphine. Following casarean delivery, pain scores will be measured
at 3, 6, 12, 24, and 36 hours.
choice" group. The choice group will be able to choose between receiving 100 mcg or 200 mcg
intrathecal morphine. The no choice group will be randomized to receive either 100 mcg or
200 mcg of intrathecal morphine. Following casarean delivery, pain scores will be measured
at 3, 6, 12, 24, and 36 hours.
This randomised controlled study will include pre-operative screening with a 2 simple
questionnaires and the patient will be randomised into a "choice" and "no choice" groups.
The group with the choice will be offered 2 different doses of intrathecal morphine (100,
200 mcg) which they can decide on after being given a standard script explaining advantages
and disadvantages of each dose. Following cesarean section patients will be followed up at
3, 6, 12, 24, 36, 48 hours following spinal injection to assess severity of pain, time to
first analgesia, total analgesia requirements, treatment of nausea, vomiting and pruritus.
questionnaires and the patient will be randomised into a "choice" and "no choice" groups.
The group with the choice will be offered 2 different doses of intrathecal morphine (100,
200 mcg) which they can decide on after being given a standard script explaining advantages
and disadvantages of each dose. Following cesarean section patients will be followed up at
3, 6, 12, 24, 36, 48 hours following spinal injection to assess severity of pain, time to
first analgesia, total analgesia requirements, treatment of nausea, vomiting and pruritus.
Inclusion Criteria:
- Women age 18-50 with singleton, term gestation fetuses and scheduled for their 1st,
2nd, or 3rd elective CS (not in labor) will be included.
Exclusion Criteria:
- Patient refusal.
We found this trial at
1
site
Stanford University School of Medicine Vast in both its physical scale and its impact on...
Click here to add this to my saved trials
